Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2003-04-30 | Dr. Dees has served as our Chief Executive Officer and as a member of our Board of Directors since we acquired PPI on April 23, 2002. |
| 2004-04-29 | H. Craig Dees, Ph.D., 52, has served as our Chief Executive Officer and as a member of our Board of Directors since we acquired PPI on April 23, 2002. |
| 2005-04-21 | H. Craig Dees, Ph.D., 53, has served as our Chief Executive Officer and as a member of our Board of Directors since we acquired PPI on April 23, 2002. |
| 2006-04-28 | H. Craig Dees, Ph.D., 54, has served as our Chief Executive Officer and as a member of our Board of Directors since we acquired Provectus Pharmaceuticals, Inc. |
| 2007-04-27 | H. Craig Dees, Ph.D., 55, has served as our Chief Executive Officer and as a member of our Board of Directors since we acquired Provectus Pharmaceuticals, Inc. |
| 2008-04-29 | H. Craig Dees, Ph.D., 56, has served as our Chief Executive Officer and as a member of our Board of Directors since we acquired Provectus Pharmaceuticals, Inc. |
| 2009-04-30 | H. Craig Dees, Ph.D., 57, has served as our Chief Executive Officer and as a member of our Board of Directors since we acquired Provectus Pharmaceuticals, Inc. |
| 2010-04-30 | H. Craig Dees is has extensive experience researching, developing, and testing potential pharmaceutical products, including our products. He holds a Ph.D. in Molecular Virology, which we believe provides us with specialized knowledge in that field. |
| 2011-05-02 | H. Craig Dees is has extensive experience researching, developing, and testing potential pharmaceutical products, including our products. He holds a Ph.D. in Molecular Virology, which we believe provides us with specialized knowledge in that field. |
| 2012-04-30 | H. Craig Dees is has extensive experience researching, developing, and testing potential pharmaceutical products, including our products. He holds a Ph.D. in Molecular Virology. |
| 2013-04-30 | H. Craig Dees, Ph.D., 61, has served as our Chief Executive Officer and as a member of our board of directors since we acquired Provectus Pharmaceuticals, Inc. |
| 2014-04-30 | H. Craig Dees, Ph.D., 62, has served as our Chief Executive Officer and as a member of our board of directors since we acquired Provectus Pharmaceuticals, Inc., a privately held Tennessee corporation ("PPI"), on April 23, 2002. |
| 2015-04-30 | H. Craig Dees has extensive experience researching, developing, and testing potential pharmaceutical products, including our products. He holds a Ph.D. in Molecular Virology. |
| 2016-11-02 | Directors and Executive Officers: H. Craig Dees, Ph.D. |
Data sourced from SEC filings. Last updated: 2025-07-01